These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. Gao Y; Wang HL; Wang WS; Liu J; Lu YG Photodiagnosis Photodyn Ther; 2016 Sep; 15():83-7. PubMed ID: 27259967 [TBL] [Abstract][Full Text] [Related]
25. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Orth G; Jablonska S; Favre M; Croissant O; Jarzabek-Chorzelska M; Rzesa G Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1537-41. PubMed ID: 206906 [TBL] [Abstract][Full Text] [Related]
26. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Horn M; Wolf P; Wulf HC; Warloe T; Fritsch C; Rhodes LE; Kaufmann R; De Rie M; Legat FJ; Stender IM; Solér AM; Wennberg AM; Wong GA; Larkö O Br J Dermatol; 2003 Dec; 149(6):1242-9. PubMed ID: 14674903 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae. Lu YG; Wu JJ; He Y; Yang HZ; Yang YD Photomed Laser Surg; 2010 Aug; 28(4):561-3. PubMed ID: 20001319 [TBL] [Abstract][Full Text] [Related]
29. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375 [TBL] [Abstract][Full Text] [Related]
30. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873 [TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application. Schacht V; Szeimies RM; Abels C Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321 [TBL] [Abstract][Full Text] [Related]
32. Epidermodysplasia verruciformis and generalized verrucosis: the same disease? Yanagi T; Shibaki A; Tsuji-Abe Y; Yokota K; Shimizu H Clin Exp Dermatol; 2006 May; 31(3):390-3. PubMed ID: 16681585 [TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus arising in a patient with epidermodysplasia verruciformis. Aghaei S; Aslani FS Lupus; 2006; 15(1):47-50. PubMed ID: 16482746 [TBL] [Abstract][Full Text] [Related]
34. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Christensen E; Mørk C; Skogvoll E Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486 [TBL] [Abstract][Full Text] [Related]
35. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Smits T; Kleinpenning MM; van Erp PE; van de Kerkhof PC; Gerritsen MJ Br J Dermatol; 2006 Aug; 155(2):429-36. PubMed ID: 16882185 [TBL] [Abstract][Full Text] [Related]